Key result
Pulmonary artery flow-directed catheters are widely used without clinical trial evidence of improved outcomes, and their use should be limited due to considerable risks of morbidity and mortality.
Population
Patients undergoing pulmonary artery catheterization
Design
Editorial
Authors
Loading...
This editorial highlights the lack of evidence supporting the widespread use of Swan-Ganz catheters and calls for urgent clinical trials to assess their risk-benefit profile.
This editorial highlights the lack of evidence supporting the widespread use of Swan-Ganz catheters and calls for urgent clinical trials to assess their risk-benefit profile.
Eugene D. Robin (1985) conducted an editorial in Patients requiring hemodynamic monitoring. Pulmonary artery flow-directed catheters was evaluated. Pulmonary artery flow-directed catheters are widely used without clinical trial evidence of improved outcomes, and their use should be limited due to considerable risks of morbidity and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: